3
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 349-359 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Beta 2-glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immume clearance of 'non-self' particles. CHONN, A., SEMPLE, S. C., and CuLus, P. R. J. Biol. Chem., 1995, 270 (43), 25845–25849.
  • Effect of liposome-muramyl tripeptide combined with recombinant canine granulocyte colony-stimulating factor on canine monocyte activity. KURZMAN, I. D., CHENG, H., and MACEWEN, E. G. Cancer Biother., 1994, 9 (2), 113–122.
  • Interaction of cationic liposomes with cells of electrically active neuronal networks in culture. AZZAZY, H. M. E., HONG, K., Wu, M. C., and GROSS, G. W. Brain Res., 1995, 695 (2), 231–236.
  • Reconstruction of membrane proteins into liposomes: application to energy-transducing membrane proteins. RIGAUD, J. L., PITARD, B., and LEVY, D. Biochim. Biophys. Acta, 1995, 1231 (3), 223–246.
  • The action of hypochlorous acid on phosphatidylcholine liposomes and dependence on the content of double bonds. Stoichiometry and NMR analysis. ARNHOLD, J., PANASENKO, O. M., SCHILLER, J., VLADINIIROV, Y. A., and ARNOLD, K. Chem. Phys. Lipids, 1995, 78(1), 55–64. The role of Fe2+ in hypochlorite-induced lipid peroxidation of liposome membranes.
  • PANASENKO, O. M., EVGINA, S. A., DRYOMINA, E. S., SHAROV, V. S., SERGIENKO, V. L., and VLADIMIROV, Y. A. Biol. Membr., 1995, 12 (2), 191–199.
  • Effect on loading on the release of 2,4-D from polymeric microspheres. AKIN, H., and HAsIREI, N. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1994, 35 (2), 765–766.
  • Study on the interaction of cholera toxin and its B-subunit with liposomes containing ganglioside GM1 and fluorescent-labelled gangliosides. SMIRNOV, 0. N., SURIN, A. M., ASTASHKIN, E. I., MIKHALEov, I. I., and MOLOTKOVSKY, J. G. Biol. Membr., 1995, 12(2), 174–184.
  • Enhancement of liposome-mediated gene transfer into vascular tissue by replication deficient adenovirus. RAJA, W. R., WEBBER, J., NAFTILAN, J., CHAPMAN, G. D., and NAFTILAN, A. J. Gene Ther., 1995, 2 (8), 521–530.
  • Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labelled cationic liposomes. HAFtA, T., ARAMAKI, Y., TAKADA, S., KOIKE, K., and TSUCHIYA, S. Gene, 1995, 159 (2), 167–174.
  • Human skin irritation of a soybeam lecithin microemulsion gel and of liposomes. DREHER, F., WALDE, P., Luis, P. L., and ELSNER, P. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 640–641.
  • Intrathecal administration of liposomal morphine in a mouse model. GRANT, G. J., CASCIO, M., ZAKOWSKI, M. I., LANGERMAN, L., and TURNDORF, H. Anesth. Analg. (Baltimore), 1995, 81 (3), 514–518.
  • Treatment of Kaposi's sarcoma with liposomal doxorubicin. BERGIN, C., O'LEARY, A., MCCREARY, C., SABRA, K., and MULC.kFlY, F. Am.. Health-Syst. Pharm., 1995, 52(18), 2001-2004. Biodistribution of liposome-associated bupivacaine after extradural administration to rabbits. BOOGAERTS, OOGAERTS. G., LAFONT, N. D., CARLINO, S., NOEL, E., RAYNAL, P., GOFFINET, G., and LEGROS, F. J. Br. y. Anaesth., 1995, 75 (3), 319–325.
  • An in vitro bioassay for quantification of bioadhesion of polymer microspheres to mucosal epithelium. JAcon, J., SANTOS, C., CARINO, G., CHICKERING, D., and 1VIATHlowiTz, E. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 312–313.
  • Biliary excretion of polystyrene microspheres after oral and parenteral administration to rats. JAN, P. U., YAMASHITA, F., NONIURA, T., TAKAKURA, Y., FLORENCE, A. T., and HASHIDA, M. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 198–199.
  • Simulated aerosol lung transfection with cationic liposome/plasmids on a cascade impactor seeded with 2-CFSMEo cells. SCHREIER, H., CONARY, J. T., CHRISTNIAN, B. W., and GAGNE, L. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 434–435.
  • Protein determination in human serum albumin microspheres with and without attached stannous ions. EPSTEIN, N. B., POTAPOVA, Z. M., KHARITONOV, Y. Y KHARLAMOV, V. T., KHLESKO, V. I., PETRIEV, V. NI., and SKVORTSOV, V. G. Pharm. Pharmacol. Lett., 1995, 5 (3), 98–100.
  • Fiber optic chemical microsensors employing optically active silica microspheres. POPE, E. J. A. Proc. SPIE-Int. Soc. Opt. Eng., 1995, 2388, 245–256. 0025-2048/96 S12.00, ..10 1996 Taylor & Francis Ltd.
  • Template-controlled synthesis of superparamagnetic goethite within macroporous poly-meric microspheres. WINNIK, F. M., NIORNEAU, A., ZIOLO, R. F., STOEVER, H. D. H., and Li, W. H. Langmuir, 1995, 11(10), 3660–3666.
  • Splitting of high-Q Mie modes induced by light backscattering in silica microspheres. WEISS, D. S., SANDootioAe, V., HARE, J., LEFEVRE, S. V., RAIMOND, J. M., and HAROCHE, S. Opt. Lett., 1995, 20(18), 1835–1837.
  • Lowering of threshold conditions for non-linear optical effects inside a microsphere. BRAUNSTEIN, D., KHAZANOV, A. M., and KOGANOV, G. A. MCLC SLIT, Sect. B: Non-linear Opt., 1995, 12 (1), 17–23.
  • Studies on intravenous injection of carmustine liposome. MA, S., DING, Y., Su, M., WANG, H., Li, D., Liu, Y., XUE, Y., Li, Z., Li, S., and Lu, X. Zhongguo Yaoxue Zazhi, 1995, 30 (6), 343–348.
  • Preparation of microcapsules of protein hydrolyzate. DONG, K., GONG, J., XU, X., and Guo, W. Zhongguo Yiyuan Yaoxue Zazhi, 1995, 15 (5), 216–217.
  • Study of agents affecting the physical properties of aspirin-tableted microcapsules. FARID, D. J., B LO RCH IAN, N., and NOKH ODCH I. y. Sch. Pharm., Med. Sci. Univ. Tehran, 1994, 4(1, 2), 27–39.
  • Microencapsulation of propranolol hydrochloride by the solvent evaporation technique. NIANEKAR, N. C., PURANIK, P. K., and JOSH, S. B. East. Pharm., 1993, 36 (426), 119-122. Formulation of controlled release egg albumin microspheres containing nifedipine. SAWANT, K. K., and MURTHY, R. S. R. East. Pharm., 1993, 36 (425), 119–120.
  • Preparation and evaluation of rifampicin microcapsules. BARIK, B. B., GUPTA, B. K., and PAL, NI. East. Pharm., 1993, 36 (428), 173–175.
  • Ibuprofen embedded wax/fat microspherules for floating drug delivery systems for controlled delivery. NATH, B. S., and REDDY, C. S. East. Pharm., 1995, 38 (452), 169–172.
  • Microencapsulation of nifedipine and its solid dispersions in HPC-MCC for sustained release. CHOWDARY, HOWDARY. P. R., and RAMESH, K. V. R. N. S. East. Pharm,, 1994, 37 (443), 127-131. Microencapsulation of salbutamol sulphate by melt dispersion technique. DHARMADHIKARI, N. B., and Josm, S. B. East. Pharm., 1994, 37 (442), 129–131.
  • Optimization of preparative conditions for polylactide (PLA) microspheres containing oval-bumin. UCHIDA, T., YOSHIDA, K., NINOMIYA, A., and GOTO, S. Chem. Pharm. Bull., 1995, 43 (9), 1569–1573.
  • Cationic liposome-mediated intravenous gene delivery. Liu, Y., Liooivr, D., ZHONG, W., Tu, G., GAENSLER, K., and Dees, R. J. Biol. Chem., 1995, 270 (42), 24864–24870.
  • Application of enteric-coated microcapsule in oral administration of bovine serum albumin into eel. NAGAI, A., and Fulizso, Y. Fish Sci., 1995, 61(5), 796–799.
  • Release control of albumin from polylactic acid microspheres. SORIANO, I., LLABRES, M., and EVORA, C. Int. y. Pharm., 1995, 125 (2), 223–230.
  • Motor and blood pressure effects of epidural sustained-release bupivacaine from polymer microspheres: a dose-response study in rabbits. MAL/NOVSKY, 3M., BERNARD, J. M., CORER, P. LE, DUMAND, J. B., LEPAGE, J. V., VERGE, R. LE, and SOURON, R. Anesth. Analg. (Baltimore), 1995, 81(3), 519–524.
  • Effect of bilayer composition on the phase behavior of liposomal suspensions containing poly(ethylene glycol)-lipids. HRISTOVA, K., KENWORTHY, A., and McINTOSH, T. J. Macromolecules, 1995, 28 (23), 7693–7699.
  • Effect of polyethylene glycol 6000 on the release of pentazocine from microcapsules. CHOUDHURY, P. K., PANDIT, J. K., BABU, R. J., and SAMPATHKUNIAR, D. East. Pharm., 1994, 37 (439), 121–124.
  • Cytokine-containing liposomes as adjuvants for HIV subunit vaccines. LACHNIAN, L., B., SHIH, L. C. N., Mei, R. X., Hu, X., BUCANA, C. D., ULLRICH, S. E., and CLELAND, J. L. AIDS Res. Hum. Retroviruses, 1995, 11(8), 921-932. Applications of liposomes. LASIC, D. D. Handb. Biol. Phys., 1995, 1A, 491–519.
  • Measurement of the thermophoretic force by electrodynamic levitation: microspheres in air. Li, W., and DAVIS, E. J. 5. Aerosol. Sci., 1995, 26 (7), 1063–1083.
  • Extinction efficiency of gradient-index microspheres. KAI, L., and D'Atessio, A. Part. Part. Syst, Charact., 1995, 12 (3), 119–122.
  • Analysis of forced convection heat transfer in microencapsulated phase change material suspensions. ZHANG, Y., and FAGHRI„N. 5. Thermophys. Heat Transfer, 1995, 9 (4), 727–732.
  • Strength of polyamide reinforced with glass microspheres. NOWAK, M. Arch. Nauk. Mater., 1994, 15 (3/4), 207–226.
  • Microencapsulation by interfacial polymerization of polyfunctional aziridines. DuELL, B. L., and PENDERGRASS, D. B. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1994, 35 (2), 51–52.
  • Storage stability of microencapsulated seal blubber oil. WANASUNDARA, U. N., and SHAFIEDI, F. 5. Food Lipids, 1995, 2 (2), 73–86.
  • Effect of microencapsulated ferrous sulphate on the oxidative stability of whole milk powder. LIN, C. W., Su, H. P., and XHANG, C. T. Shipin Kexue (Taipei), 1995, 22 (2), 141–148.
  • Antimetastatic effect of immunization with liposome-encapsulated tumour cell-membrane proteins obtained from experimental tumours. ALINO, S. F., LEJARRETA, M., ALFARO, J., IRUARRIZAGA, A., BOBADILLA, M., BLAYA, C., and CRESPO, J. Immunopharmacol. Immunotoxicol., 1995, 17 (3), 419–436.
  • Photodynamic efficiency of liposome-administered tetramethyl hematoporphyrin in two human bladder cancer cell lines. BACHOR, R., REICH, E., MILLER, K., RUECK, A., and HAUTMANN, R. Urol. Res., 1995, 23 (3), 151–136.
  • Permanent enzyme microencapsulation in reverse micellar media. ROBLEDO, L., VILAS, V., and OTERO, C. Ann. N Y Acad. Sci., 1995, 750, 89–93.
  • Inter-particle interactions of liposomes and their pattern formation. NIATsumuEA, H., and FURUSAWA, K. Denshi Gijutsu Sogo Kenkyusho Iho, 1995, 59 (8), 555–569.
  • Spreading kinetics of dimyristoylphosphatidylcholine liposomes at the air/water interface below and above the main phase-transition temperature. PANAIOTOV, I., IVANOVA, T., BALASHEV, K., and PROUST, J. Colloids Surf., A, 1995, 102, 159–165.
  • Identification of phosphatidate non-lamellar phases on liposomes by flow cytometry. BAEZA, I., AGUILAR, L., ALVARADO, A. F., SOTO, C., ESCOBAR, G. A., MONDRAGON, R., GONZALEZ, S., IBANEZ, M., and WoNc, C. Biochem. Cell Biol., 1995, 73 (5 and 6), 289–297.
  • Hypochlorite interaction with hydroperoxides and other products of lipid peroxidation of phosphatidylcholine liposomes. PANASENKO, 0. M., ARNIOLD, J., VLADINIIROV, Y. A., and SERGIENKO, V. I. Biokhimiya (Moscow), 1995, 60 (9), 1419–1428.
  • Reactive entrapment of cancer-causing agents in semi-permeable magnetically-recoverable microcapsules used for gastrointestinal monitoring. O'NEILL, I., ELLuL, A., and RIDGWAY, 0. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1994, 35 (2), 79–80.
  • Incorporation of the cholera toxin receptor in phospholipid-covered polystyrene micro-spheres. SICCHIEROLLI, S. M., and CARMONA, R. A. NI. Colloids Surf., B, 1995, 5 (1/2), 57–61.
  • Inhibitory effects of catechol derivatives on oxidation of soybean phosphatidylcholine liposomes induced by hydrophillic and hydrophobic free radical initiators. KITAGAWA, S., SAKUMA, T., and YONEMURA, S. Chem. Pharm. Bull., 1995, 43 (8), 1263–1266.
  • Effect of isocarbacyclin methyl ester incorporated in lipid microspheres on experimental models of peripheral obstructive disease. MURAKAMI, T., SAWADA, K., TANEDA, K., HAYASHI, M., KATSUURA, Y., TANABE, H., KIYOKI, M., and ARAKI, H. Arzneim. Forsch., 1995, 45 (9), 991–994.
  • Effect of isocarbacyclin methyl ester incorporated into lipid microspheres on cutaneous blood flow in rat. SAWADA, K., TANEDA, K., KATSUURA, Y., TANABE, H., KIYOKI, M., and ARAKI, H. Arzneim. Forsch., 1995, 45 (9), 988–990.
  • Vasorelaxant effect of isocarbacyclin methyl ester incorporated into lipid microspheres on isolated canine arteries. SAWADA, K., AOKI, K., KATSUURA, Y., TANABE, H., KIYOKI, M., and ARAKI, H. Arzneim. Forsch., 1995, 45 (9), 985–988.
  • Ex vivo anti-platelet effects of isocarbacyclin methyl ester incorporated in lipid microspheres in rabbits. INouE, K., AOKI, Y., HAYASHI, M., KITAHARA, S., TANABE, H., KIYOKI, M., and ARAKI, H. Arzneim. Forsch., 1995, 45 (9), 980–984.
  • Polystyrene microspheres decrease bronchial artery resistance in anesthetized sheep. PEARSE, D. B., FESSLER, H. E., and WAGNER, E. M. Am. y. Physiol., 1995, 269 (3, Pt. 2), H1037-H1043. Antitumor reactivity induced by liposomal MTP-PE in a liver metastasis model of colon cancer in the rat. THOMAS, K., NIJENHUIS, A. M., DONTJE, B. H. J., DAEMEN, T., and SCHERPHOF, L. Clin. Exp. Metastasis, 1995, 13 (5), 328–336.
  • Liposomal muramyl tripeptide upregulates adhesion molecules on the surface of human monocytes. ASANO, T., NIEINTyEE, B. W., BEDNARCZYK, J. L., WYGANT, J. N., and KLEINERNIAN, E. S. Oncol. Res., 1995, 7 (5), 253–257.
  • Liposomal rifamycins: in vivo evaluation. CRUZ, M. E., GASPAR, M. M., MIMOSO, I. M., PORTAELS, F., and SILVA, M. T. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 462–463.
  • Lymphogenic inflow into the lesser circulation of oral rifampicin in standard and liposomal forms. PETRENKO, T. I., URSOV, I. G., KURUNOV, Y. N., BORODIN, Y. I., and SIDOROVA, L. D. Probl. Tuberk., 1995 (3), 53–54.
  • Blood urea clearance with microencapsulated urease. LEE, K. B., BOADI, D. K., and NEUFELD, R. J. J. Theor. Biol., 1995, 175 (3), 295–303.
  • Gene transfer by HVJ-liposomes for gene therapy. KANEDA, Y. Saishin Igaku, 1995, 50 (Suppl. 601), 1708–1717.
  • Enhancement of local electric field by a metal microsphere and surface enhanced Raman scattering of silver salts of high molecular weight carboxylic acids. YONEZAWA, Y MIYANIA, T., and SATO, T. Nippon Shashin Gakkaishi, 1995, 58(2), 109–121.
  • TLC characterization of liposomes containing D-myo-inositol derivatives. BRAILOIU, E., HUHUREZ, G., SLATINEANU, S., FILIPEANU, C. M., COSTULEANU, M., and BRANISTEANU, D. D. Biomed. Chromatogr., 1995, 9 (4), 175–178.
  • Conjugation of cholera toxin or its B subunit to liposomes for targeted delivery of antigens. HAROKOPAKIS, E., CHILDERS, N. K., MicHALEa, S. M., ZHANG, S. S., and TONIASI, M. J. Immunol. Methods, 1995, 185 (1), 31–42.
  • A method for fabrication of monodisperse hydrogel particles using liposomes. MoNsHirouRI, M., and RUDOLPH, A. S. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1994, 35 (2), 721–722.
  • Thermosensitive sterically stabilized liposomes: formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma. GABER, M. H., HONG, K., HUANG, S. K., and PAPAHADJOPOULOS, D. Pharm. Res., 1995, 12 (10), 1407–1416.
  • Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules. WALTER, K., WEISS, G., LAICHER, A., and STANISLAUS, F. Arzneim. Forsch., 1995, 45 (8), 886–890.
  • Liposomes for intracellular delivery of antibiotics in infection. GULYAEV, A. Y., KIVNIAN, G. Y., GIBENKO, L. V., and YERNIEKBAYEVA, B. A. Khim. Farm. Zh., 1994, 28 (9), 12–14.
  • Immunological characterization of phosphatidylethanol-containing liposomes. KuLIK, L. N., IVANOV, V. S., and KISEL, M. A. Biotekhnologiya, 1995, (3–4), 38–40.
  • Swelling behaviour of gelatin microspheres crosslinked with dl-glyceraldehyde. The effect of the preparative factors. VANDELLI, M. A., PIFFERI, G., SEGHIZZI, R., and CAMERONI, R. Pharm. Pharmacol. Lett., 1995, 5 (3), 116–119.
  • Preparation and characteristics of surface-modified albumin microspheres with metho-trexate. HWANG, S. J., Jo, H. B., RHEE, G. J., and KINI, C. K. Yakche Hakhoechi, 1995, 25 (2), 101–108.
  • Study on residual organic solvent and physicochemical characteristics of polylactic acid microspheres containing carmofur. NIABUCHI, K., NAKAYAMA, A., HIRANO, H., and IWAMOTO, K. Byoin. Yakugaku, 1995, 21(4), 310–318.
  • Polyurethane microspheres as drug carriers. REDDY, P. V. S., MAHESH, G. N., RAMESH, S., SIVAKUMAR, P. A., and RADHAKRISIINAN, G. Macromol. Rep., 1995, A32 (Supp1. 5 and 6), 789–799.
  • Optimization of microencapsulation of acrylic adhesives. GIROUD, F., PealloT, J. M., BRUN, H., and POUYET, B. 7. Microencapsulation, 1995, 12 (4), 389–400.
  • Experimental and clinical studies of degradable starch microspheres in the treatment of hepatic neoplasm. I. Experimental study. YAMADA, T. Nippon Igaku Hoshasen Gakkai Zasshi, 1995, 55 (9), 663–669.
  • Oral immunization with antigens and adjuvants coencapsulated in derivatized amino acid microspheres. SANTIAGO, N., MivaA, F. J., KU:WAR, M., LEONE, B. A., DEMORIN, F., and HAAS, S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 576–577.
  • Immunoadjuvant action of liposomes containing interleukin-2 as a co-adjuvant. GURSEL, M., and GREGORIADIS, G. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 572–573. Spontaneous transfer of viral protein from membrane of influenza virus-infected cells to liposomes is dependent on the diameter of receiver. KOGURE, K., ITOH, M., HAYASHI, K., and UENO, M. Biol. Pharm. Bull., 1995, 18(8), 1168–1170.
  • Development and characterization of liposomal tumour necrosis factor (TNF). KLOSTERGAARD, J., AKIMARU, K., SONIA, G. I., and LODATO, R. F. 7. Liposome Res., 1995, 5 (3), 491–502. Liposomes as immunoadjuvants for saccharide antigens. SNIPPE, H., and VERHEUL, A. F. M. 7. Liposome Res., 1995, 5 (3), 453–465.
  • Phospholipids, liposomes, and nanoemulsions. Part 2. Skin effects and product safety. GAREISS, J., HoFF, E., and GHYCZY, M. Parfuem Kosmet, 1995, 76 (3), 152–155.
  • Microencapsulated phase change material for heat transfer enhancement. SENGUPTA, S. jAERI-Conf., 1995, 95–011. 65–93.
  • 'Perfusion chromatography'. The effects of intra-particle convective velocity and micro-sphere size on column performance. LIAPIS, A. I., Xu, Y., CROSSER, 0. K., and TONGTA, A. 7. Chromatogr., A, 1995, 702 (1 and 2), 45–57.
  • Triggerable controlled release systems. 11. Photosensitive microcapsules with water erodible core. TSUEI, A., and MITRA, S. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1994, 35 (2), 57–58.
  • Triggerable controlled release systems. 1. Alkaline pH-erodible microspheres. MITRA, S., and Tsuet, suet. C. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1994, 35 (2), 55-56. Effect of operating variables and monomers on the formation of polyurea microcapsules. NI, P., ZHANG, M., and YAN, N. j. Membr. Sci., 1995, 103 (1-2), 51–55.
  • Triboelectric control of pigmented microencapsulated coloured toners. MoreAT, K. A., and MARTIN, T. I. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1994, 35 (2), 69–70.
  • The possibilities of microencapsulated antioxidants for polymers. I. A theoretical analysis. BILLINGHAM, N. C., and GARCIA, T. P. Polym. Degrad. Stab., 1995, 48 (3), 419–426.
  • Characterization of release behaviour of microcapsules loaded with xylene using thermo-gravimetric analysis. MATHIAS, P. A., and THIES, C. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1994, 35 (2), 67–68.
  • Syntheses of new polyphosphates as liposomal materials. Liu, Z., &No, C., FAN, C., and ZHUO, R. Gaofenzi Xuebao, 1995, (4), 483–487.
  • Affinity microcapsules: chitosan-alginate membrane stability and isolation of bovine serum albumin. ACHAW, 0. W., and GOOSEN, M. F. A. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1994, 35 (2), 75–76.
  • Improving the n-3 HUFA composition of Artemia using microcapsules containing marine oils. SOUTHGATE, P. C., and Lou, D. C. Aquaculture, 1995, 134 (1, 2), 91–99.
  • Microencapsulation of lobster carotenoids within poly(vinyl alcohol) and poly(D, L-lactic acid) membranes. SUN, Z. M., PONCELET, D., CONWAY, J., and NEUFELD, R. J. I. Micro-encapsulation, 1995, 12 (5), 495–504.
  • Encapsulation of neutrase in liposomes to accelerate the aging of Cheddar cheese. FRESTA, M. Boll. Chim. Farm., 1995, 134 (4), 220.
  • The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homolog of human CD68. RAMPRASAD, M. P., FISCHER, W., W/TZTUM, J. L., SAMBRANO, G. R., QUEHENBERGER, 0., and STEINBERG, D. Proc. Natl. Acad. Sci. USA, 1995, 92 (21), 9580–9584.
  • Influence of liposome-encapsulated yeast Cu/Zn superoxide dismutase on the phagocytosis of mouse peritoneal-exudation cells. VALEVA, V., STEFANOVA, Z., YANCHEV, I., and NEYCHEV, H. Dokl. Bulg. Akad. Nauk., 1994, 47 (7), 83–86.
  • Cytokine-encapsulated liposomes covalently coupled to tumour cells is an alternative to gene-transfected tumour cells as vaccines? FALKENBERG, F. W., and REIMER, M. Vaccine Res., 1995, 4(2), 105–111.
  • Radioimmunoanalysis of antibodies obtained by a liposomal adjuvant. BEJAN, A., Suciu, M., DOROBANTU, I., MAICAN, A., and TURCU, GR. J. Radioanal. Nucl. Chem., 1995, 200 (6), 475–482.
  • Liposome fusion induced by a Mr 18 000 protein localized to the acrosomal region of acrosome-reacted abalone spermatozoa. SWANSON, W. J., and VACQUIER, V. D. Biochemistry, 1995, 34 (43), 14202–14208.
  • Properties of immobilized-liposome-chromatographic supports for interaction analysis. BREKKAN, E., Lu, L., and LUNDAHL, P. J. Chromatogr., A, 1995, 711 (1), 33–42.
  • Differential scanning calorimetry and Fourier-transform infrared spectroscopic studies of liposomes and biomembranes. MCELHANEY, R. N. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 5–6.
  • Molecular order and mobility within liposomal membrane made from highly fluorinated phospholipids. SANTAELLA, C., and VIERLING, P. Chem. Phys. Lipids, 1995, 77 (2), 173–177.
  • Liposome formation from the preparation of the lipid cornea layers. Characterization and interactions with surfactants. LOPEZ, 0., DE LA IVIAZA, A., CODERCH, L., and PARRA, J. L. Commun. jorn. Corn. Esp. Deterg., 1995, 26, 79–93.
  • Structural models of plasmatic membranes based on liposomes. LYUBESHKIN, A. V., SEBYAKIN, Y. L., and YEVSTIGNEYEVA, R. P. J. Biochem. Organ., 1994, 1(3), 197–213.
  • Repeated intravenous administration of liposome-encapsulated muramyl tripeptide-phosphatidyl-ethanolamine diminishes cytotoxic potential of subpopulation of rat liver macrophages. HOEDEMAKERS, R. M. J., SCHERPHOF, G. L., and DAENIEN, T..7. Liposome Res., 1995, 5 (3), 581–603.
  • Efficacy of encapsulated adriamycin in the liposomes on mice SRS lymphoma. Wu, K., FAN, J., GAO, X., and JiN, B. Zhongguo Yaolixue Tongbao, 1993, 9 (4), 268–270.
  • The antitumour activity and toxic side effects of polyethyleneglycol-coated liposomes containing adriamycin. SADZUKA, Y NAKAI, S. I., MivAcisHINIA, A., NOZAWA, Y., and HIROTA, S. Drug Delivery Syst., 1995, 10 (3), 181–187.
  • Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet protects against hypocalcemia induced by free foscarnet. OMAR, R. F., DUSSERRE, N. D., and BERGERON, M. G. Antimicrob. Agents Chemother., 1995, 39 (9), 1973–1978.
  • Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice. VAN ETTEN, E. W. M., TEN, K. M. T., STEARNE, L. E. T., and BARKER, W. I. A. J. M. Antimicrob. Agents Chemother., 1995, 39 (9), 1954–1958.
  • Liposome immunosensing devices for environmental contaminant screening. REEVES, S. G., SIEBERT, S. T. A., ROBERTS, NI. A., and DURST, R. A. Trends Anal. Chem., 1995, 14(7), 351–335.
  • Design guidelines and water extraction synthesis capabilities for hollow ceramic micro-spheres for low-dielectric-constant inorganic substrates. Liu., J. G., and WILCOX, D. L. SR. Mater. Res. Soc. Symp. Proc., 1995, 372 231–237.
  • Review of low dielectric constant thick film electronic ceramics using hollow microspheres. KELLERIMAN, D. W. Mater. Res. Soc. Symp. Proc., 1995, 372, 239–245.
  • Heparin immobilization onto PHEMA microspheres and determination of anticoagulant activity of immobilized heparin. DENIZLI, A., and PISKIN, E. Turk. 1. Chem., 1995, 19 (2), 114–126.
  • A rigorous theory of remote loading of drugs into liposomes. CEH, B., and LASIC, D. D. Langmuir, 1995, 11(9), 3356–3368.
  • Microcapsules obtained from complex coacervation of collagen and chondroitin sulfate. SHAG, W., and LEONG, K. W. y. Biomater. Sci., Polym. Ed., 1995, 7 (5), 389–399.
  • A new thermodynamic model to predict protein encapsulation efficiency in poly(lactide) microspheres. GANDER, B., NIERKLE, H. P., NGUYEN, V. P., and Ho, N. T. J. Phys. Chem., 1995, 99 (43), 16144–16148.
  • The microencapsulation of protein using a novel ternary blend based on poly(epsilon-caprolactone). HUATAN, H., COLLETT, J. H., and ATTWOOD, D. J. Microencapsulation, 1995, 12 (5), 557–567.
  • Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes. ARICA, B., OEZER, A. Y., ERCAN, M. T., and HINCAL, A. A. y. Microencapsulation, 1995, 12(5), 469–483.
  • Modification of alpha2-macroglobulin into a macrophage-activating factor through the action of liposome-stimulated B-cell membranous glycosidases. MuRm, M., ARAMAKI, Y., and TSUCHIYA, S. Immunology, 1995, 86 (1), 58–63.
  • Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. PARK, T. G. Biomaterials, 1995, 16 (15), 1123–1130.
  • Engineered liposomes and virosomes for delivery of macromolecules. GRIMALDI, S., GIULIANI, A., FERRONI, L., List, A., SANTORO, N., and Pozzi, D. Res. Virol., 1995, 146 (4), 289–293.
  • Physical stability of different liposome compositions obtained by extrusion method. ARNIENGOL, X., and ESTELRICH, J. y. Microencapsulation, 1995, 12(5), 525–535.
  • Enhanced in vivo performance of liposomal indomethacin derived from effervescent granule-based proliposomes. KATARE, O. P., VyAs, S. P., and DIXIT, V. K. J. Micro-encapsulation, 1995, 12 (5), 487–493.
  • Identification of the serum factor required for liposome-primed activation of mouse peri-toneal macrophages. Modified alpha2-macroglobulin enhances Fc.gamma. receptor-mediated phagocytosis of opsonized sheep red blood cells. MURAI, M., ARAMAKI. Y., and TSUCHIYA, S. Immunology, 1995, 86 (1), 64–70.
  • Degradability and antigen-release characteristics of polyester microspheres prepared from polymer blends. SAH, H., and CHIEN, Y. W. J. Appl. Polym. Sci., 1995, 58 (1), 197–206.
  • Preparation and characterization of crosslinked gelatin microspheres. AKIN, H., and HASIRCI, N. y. Appl. Polym. Sci., 1995, 58 (1), 95–100.
  • Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. :Um-1AT°, R. I., KAWABATA, K., NOMURA, T., TAKAKURA, Y., HASHIDA, and MiTsuRu. J. Pharm. Sci., 1995, 84(11), 1267–1271.
  • Biodegradable ion-exchange microspheres based on modified polylysines. CREMERS, H. F. M., LENS, ENS. P., SEYMOUR, L., and FEHEN, J. J. Controlled Release, 1995, 36 (1-2), 167-179. Lung targeting gelatin microspheres of mitoxantrone. WANG, J. H., Lc, B., Xu, P. L., BAO, D. Y., and ZHANG, Z. R. Yaoxue Xuebao, 1995, 30 (7), 549–555.
  • CDDP-albumin microspheres for hepatic arterial chemoembolization. ZHANG, Y. Q., JIANG, X. T., SUN, Q. R., ZHANG, G. Q., and WANG, V. Yaoxue Xuebao, 1995, 30 (7), 543–548.
  • Effects of H+ liberated from hydrolytic cleavage of polyester microcapsules on their permeability and degradability. SAH, H,, and CHIEN, Y. W. J. Pharm. Sci., 1995, 84 (11), 1353–1359.
  • Microsphere formation in a series of derivatized alpha-amino acids: properties, molecular modeling, and oral delivery of salmon calcitonin. LEONE, B. A.,, McINNEs, C., WANG, N., DEMoruN, F., ACHAN, D., LERCARA, C., SARUBBI, D., H.AAS, S., PRESS, J., et al. J. Med. Chem., 1995, 38 (21), 4257–4262.
  • Release of drugs from ethyl cellulose microcapsules (diffusion pellets) with pore formers and pore fusion. GUNDER, W., LIPPOLD, B. H., and LIPPOLD, B. C. Eur. J. Pharm. Sci., 1995, 3 (4), 203–214.
  • Liposomal hepatitis A vaccine and liposomal multiantigen combination vaccines. GLUECK, R. 5. Liposome Res., 1995, 5 (3), 467–479.
  • Use of genetically engineered lipid-tagged antibody to generate functional europium chelate-loaded liposomes. Application in fluoroimmunoassay. LAUKKANEN, M. L., ORELLANA, A., and KEINAENEN, K. 5. Immunol. Methods, 1993, 185 (1), 95–102.
  • Liposome ocular delivery systems. MeisNER, D., and Mem, M. Adv. Drug Delivery Rev., 1995, 16 (1), 75–93.
  • Microspheres and nanoparticles used in ocular delivery systems. ZINIMER, A., and KREUTER, J. Adv. Drug Delivery Rev., 1995, 16 (1), 61–73.
  • Liposomal delivery of peptides and proteins. STORM, G., KOPPENHAGEN, F. J., HEEREMANS, A. L. M., VINGERHOEDS, M. H., WOODLE, M. C., and CRONINIELIN, D. J. A. 5. Liposome Res., 1995, 5 (3), 481–489.
  • Microencapsulated redox catalysts for a dental glass ionomer cement. MITRA, S. B., MiTaA, S., GARTNER, J. M., and KEDROWSKI, B. L. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) 1994, 35 (2), 77–78.
  • Preparation of extractive microcapsules with supported liquid membrane. YOSHIZAWA, H., ANWAR, M., MOTONIURA, K., UEMURA, Y., Ipcm, K., OHTAKE, T. A., KAWANO, Y., and HATATE, Y. Solvent Extr. Res. Dev., Jpn, 1995, 2, 185–195.
  • Synthesis of polyurethanes suitable for microencapsulation techniques. II. Synthesis of linear polyurethanes. BROSSE, C., FONTAINE, L., SOUTIF, J. C., and BROSSE, J. C. Eur. Polym. y., 1995, 31(10), 931–936.
  • Methodology and nomenclature in microencapsulation. ARSHADY, R. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1994, 35 (2), 63–64.
  • Design of microsphere surfaces and its application. KAWAGUCHI, H. Kobunshi, 1995, 44 (5), 294–297.
  • Real-time analysis of liposomal trafficking in tumour-bearing mice by use of positron emission tomography. OKU, N., TOKUDOME, Y., TSUKADA, H., and OKADA, S. Biochim. Biophys. Acta, 1995, 1238 (1), 86–90.
  • Novel magnetic microspheres on the basis of poly(vinyl alcohol) as affinity medium for quantitative detection of glycated Hb. MUELLER, S. D., and BRUNNER, H..7. Chromatogr., A, 1995, 711 (1), 53–60.
  • Antioxidant protection of egg lecithin liposomes during sonication. GABRIELSIC.A, J., SARAPUK, J., and PRZESTALSKI, S. Z. Naturforsch., C: Biosci., 1995, 50 (7/8), 561–564.
  • Bioimaging of myeloperoxidase release into phagolysosome of viable polymorphonuclear leukocytes and reaction of the enzyme with microspheres using a highly sensitive analyser system, IMRAS. SUZUKI, K., HOSAKA, S., IVIORIKAWA, K., SUZUKI, M., SUZUKI, S., MIYOSHI, M., FUJITA, M., and Mizuxo, S. Bioimages, 1993, 1(1), 13–20.
  • Microencapsulation of 0/W emulsions by formation of a protein surfactant insoluble complex. MAGDASSI, S., and VINETSKY, Y..7. Microencapsulation, 1995, 12 (5), 537–545.
  • ATP synthesis by the F0F1-ATPase from the thermophillic Bacillus PS3 co-reconstituted with bacteriorhodopsin into liposomes. Evidence for stimulation of ATP synthesis by ATP bound to a noncatalytic binding site. RICHARD, P., PITARD, B., and RIGAUD, J. L..7. Biol. Chem., 1995, 270 (37), 21571–21578.
  • Effect of lipid ozonation products on liposomal membranes detected by laurdan fluorescence. SALGO, M. G., CUETO, R., and PRYOR, W. A. Free Radical. Biol. Med., 1995, 19 (5), 609–616.
  • Pro-oxidant effects of cross-linked hemoglobins explored using liposome and cytochrome c oxidase vesicle model membranes. ROGERS. M. S., PATEL, R. P., REEDER, B. J., SARTI, P., WILSON, M. T., and ALAYASH, A. I. Biochem. y., 1995, 310 (3), 827–833.
  • Liposome solubilization on octyl glucoside. DE LA MAZA, A., and PARRA, J. L. Comun. Yorn. Corn. Esp. Deterg., 1995, 26, 353–367.
  • Interaction of anionic/nonionic surfactant mixtures with phosphatidylcholine liposomes. DE LA MAZA, A., and PARRA, J. L. Arch. Biochem. Biophys., 1995, 322 (1), 167–173.
  • A possible route for the formation of protoprotein and its microspheres from primitive gases under possible prebiotic conditions. HARADA, K., and MizurooTo, H..7. Biol. Phys., 1994, 20(1–4), 123–127.
  • Liposome aggregation: promoted by trypsin and papain in the absence of cations. Ts, A. C. H., and TSAO, F. H. C. y. Liposome Res., 1995, 5 (3), 571–580.
  • Liposomes in reconstitution of ion-pumps. Electrogenic properties of the Na, K +-ATPase and the sarcoplasmic Ca2+-ATPase. CORNELIUS, F..7. Liposome Res., 1995, 5 (3), 399-412. Flow-injection liposome immunoanalysis (FILIA) with electrochemical detection. EDWARDS, A. J., and DURST, R. A. Electroanalysis, 1995, 7 (9), 838–845.
  • Pseudomonas syringae pv. syringae phytotoxins reversibly inhibit the plasma membrane H+-ATPase and disrupt unilamellar liposomes. CAMONI, L., Di GIORGIO, D., MARRA, M., ADUCCI, P., and BALLIO, A. Biochem. Biophys. Res. Commun., 1995, 214 (1), 118–124.
  • Liposome-encapsulated DNA-mediated gene transfer and synthesis of human factor IX in mice. BARU, M., AXELROD, J. H., and NUR, I. Gene, 1995, 161 (2), 143–150.
  • Differential effect of triiodothyronine and thyroxine on liposomes containing cholesterol: physiological speculations. CHEHIN, R. N., RINTOUL, M. R., MORERO, R. D., FARIAS, R. N. .7. Membr. Biol., 1995, 147 (2), 217–212.
  • Complement activation by liposome-encapsulated hemoglobin in vitro: The role of endotoxin contamination. SZEBENI, J., WASSEF, N. M., RUDOLPH, A. S., and ALVING, C. R. Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 23 (3), 355–363.
  • Embryotoxicity of free and liposome-encapsulated taxol in the chick. SCIALLI, A. R., DESEsso, J. M., RAHMAN, A., HUSAIN, S. R., and GOERINGER, G. C. Pharmacology, 1995, 51 (3), 145–151.
  • Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumour dissemination in the murine peritoneal cavity. AOKI, K., YOSHIDA, T., SUGINIURA, T., and TERADA, M. Cancer Res., 1995, 55 (17), 3810–3816.
  • Low-dielectric-constant laminates containing microspheres. JAPP, R. M., and PAPATHOMAS, K. I. Mater. Res. Soc. Symp. Proc., 1995, 372, 221–229.
  • A NMR study of the interaction of silica with dipalmitoylphosphatidylcholine liposomes. CHUNBO, Y., DAQING, Z., AIZHUO, L., and JIAZUAN, N. 1. Colloid Interface Sci., 1995, 172 (2), 536–538.
  • Interactions between temperature-sensitive hydrogel microspheres and granulocytes. ACHHIA, K., OJIMA, R., KASUYA, Y., FUJINIOTO, K., and KAWAGUCHI, H. Polym. Adv. Technol., 1995, 6 (7), 534–540.
  • Liposome formation in microgravity. CLAASSEN, D. E., and SPOONER, B. S. Adv. Space Res., 1996, 17 (6/7), 151–160.
  • Precomeal clearance of mucoadhesive microspheres from the rabbit eye. DURRANI, A. M., FARR, S. J., and KELLAWAY, I. W..7. Pharm. Pharmacol., 1995, 47 (7), 581–584.
  • The transfer of polystyrene microspheres from the gastrointestinal tract to the circulation after oral administration in the rat. EYLes, J., ALPAR, H. 0., FIELD, W. N., LEWIS, D. A., KESWICK, m. 1. Pharm. Pharmacol., 1995, 47 (7), 561–565.
  • Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation. UCHIDA, T., GOTO, S., and FOSTER, T. P. _7. Pharm. Pharmacol., 1995, 47 (7), 356–560.
  • Encapsulation of thioguanine in liposomes. FORADADA, M., and ESTELRICH, J. Int. y. Pharm., 1995, 124 (2), 261–269.
  • Development of microcapsule production technology for high performance controlled drug release. LEE, H. B., YOOK, S. H., and Clio, S. H. Kobunja Krvahak Krva Kisul, 1993, 4 (6), 468–469.
  • Encapsulation of vincristine in liposomes reduces its toxicity and improves its antitumor efficacy. BON, N. L., BALLY, M. B., CuLus, P. R., NlAyea, L. D., and WEBB, M. S.7. Liposome Res., 1995, 5 (3), 523–541.
  • Effect of hyperosmolar mannitol on the delivery of high molecular weight substances entrapped in liposomes to the brain and cultured C6 glioma cells. GOMES, I., and SIIARMA, S. K. y. Clin. Biochem. Nutr., 1995, 18(3), 133–144.
  • Preparation of liposomes with palmitic-antibody and targeting in vitro. Hou, X. P., NING, B. M., and GAO, X. Z.7. Chin. Pharm. Sc., 1995, 4 (2), 62–66.
  • Designing of thermosensitive liposomes from natural lipids for multimodality cancer therapy. CHELVI, T. P., and RALHAN, R. Int. y. Hyperthermia, 1995, 11(5), 685–695.
  • The effect of particle microstructure on the somatostatin release from poly(lactide) micro-spheres prepared by a W/O/VV solvent evaporation method. HERRNIANN, J., and BODNIEIER, R. _7. Controlled Release, 1995, 36 (1–2), 63–71.
  • Spray-dried albumin microspheres containing nicardipine. CONTE, U., GIUNCHEDI, P., NIAGGI, L., and Toaae, M. L. Eur. y. Pharm. Biopharm., 1994, 40 (4), 203–208.
  • Identification of some of the physicochemical characteristics of microspheres which in-fluence the induction of the immune response following mucosal delivery. ALPAR, H. O., and ALMEIDA, A. J. Eur. y. Pharm. Biopharm., 1994, 40 (4), 198–202.
  • Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. OH, Y., Nix, D. E., and STRAUBINGER, R. M. Antimicrob. Agents Chemother., 1995, 39(9), 2104–2111.
  • Buffer controlled release of indomethacin from ethyl cellulose microcapsules. TIRKKONEN, S., UaTTI, A., and PARONEN, P. Int. y. Pharm., 1995, 124 (2), 219–229.
  • Lymphoid tissues targeting of lipsome-encapsulated 2',3'-dideoxyinosine. HARVIE, P., DESORMEAUX, A., GAGNE, N., TREMBLAY, M., BEAUCHAMP, D., and BERGERON, M. G. AIDS (London), 1995, 9 (7), 701–707.
  • Interactions between bacteriohopane-32,33,34,35-tetrol and liposomal membranes composed of dipalmitoylphosphatidylcholine. CHEN, Z., SATO, Y., NAKAZAWA, I., and Suzum, Y. Biol. Phartn. Bull., 1995, 18 (3), 477–480.
  • Effect of cetylmannoside modification on the alternative complement pathway activation of liposomes in rat serum. MATSU°, H., YAMASHITA, C., AKIYANIA, K., and KIWADA, H. Biol. Pharm. Bull., 1995, 18 (4), 581–585.
  • Use of antioxidants during preparation of alpha-tocopherol-enriched liposomes. PEKINER, B., and PENNOCK, J. F. Nutr. Res. (N Y), 1995, 15 (6), 795–802.
  • Biodegradable microcapsules containing an anticancer drug: experimental studies of drug release and toxicity. NIURATA, K. J. jpn. Soc. Cancer Ther., 1995, 30 (6), 883–896.
  • Characterization of in-vitro release of sulfamethizole from Eudragit RL 100 microspheres. SA, B., and TAMILVANAN, S. Indian Drugs, 1995, 32 (4), 176–183.
  • Pressure induced fusion (PIF) liposomes: a solventless sterilizing method for producing large phospholipid vesicles. PERKINS, W. R., DAUSE, R. B., Li, X., DAVIS, T. S., AHL, P. L., MINCHEY, S. R., TARASCHI, T. F. ERRAMILLI, S., GRUNER, S. M., and JANOFF, A. S. 1. Liposome Res., 1995, 5 (3), 605–626.
  • The use of hydrophobic dye molecules in monitoring the liposome bilayer microenviron-ment and locating block copolymers added to enhance liposome steric stability. KOSTARELOS, K., LUCKHANI, P. F., and TADROS, T. F. _7. Liposome Res., 1995, 5 (3), 443–452.
  • Mechanistic study on toxicity of positively charged liposomes containing stearylamine to blood. NISHIYA, T., LAM, R. T. T., ENG, F., ZEREY, M., and LAU, S. Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1995, 23 (4), 505–512.
  • Antitumor effects of liposomal IL1 alpha and TNF alpha against the pulmonary metastases of the B16F10 murine melanoma in syngeneic mice. SAITO, M., FAN, D., and LACHMAN, L. B. Clin. Exp. Metastasis, 1995, 13 (4), 249–259.
  • Biodegradable microspheres XVIII: the adjuvant effect of polyacryl starch microparticles with conjugated human serum albumin. DEGLING, L., and STJAERNKVIST, P. Vaccine, 1995, 13 (7), 629–636.
  • Novel developments in liposomal delivery of peptides and proteins. STORM, G., KOPPENHAGEN, F., HEEREMANS, A., VINGERHOEDS, M., WOODLE, M. C., and CROMMELIN, D. J. A..7. Controlled Release, 1995, 36 (1–2), 19–24.
  • Basic study and application of functional liposomes. Oxo, N. Yakugaku Zasshi, 1995, 115 (7), 483–498.
  • Mullite microsphere-filled lightweight calcium phosphate cement slurries for geothermal wells: setting and properties. SUGAMA, T., CARCIELLO, N. R., NAYBERG, T. M., and BROTHERS, L. E. Cem. Concr. Res., 1995, 25 (6), 1305–1310.
  • Hollow and solid spheres and microspheres: science and technology associated with their fabrication and application. WILCOX, D. L. SR., BERG. M., BERNAT. T., KELLERMAN, D., and COCHRAN, J. K. JR., Editors. Mater. Res. Soc., Pittsburgh, Pa., 1995, 296 pp.
  • Preparation of polymer microspheres by radiation-induced polymerization. NAKA, Y., YAMAMOTO, Y., YOSHIDA, Y., and TAGAWA, S. JAERI-Conf., Proceedings of the 6th Japan-China Bilateral Symposium on Radiation Chemistry, 1995, 95–003. 588–592.
  • Liposomal encapsulation of beta-galactosidase: Comparison of two methods of encapsula-tion and in vitro lactose digestibility. RAO, D. R., CHAWAN, C. B., and VEERAMACHANENI, R. .7. Food Biochem., 1995, 18 (4), 239–251.
  • Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expres-sion and radioprotection. SALKOWSKI, C. A., NETA, R., WYNN, T. A., STRASSMANN, G., VAN ROOIJEN, N., and VOGEL, S. N. y. Immunol., 1995, 155 (6), 3168–3179.
  • Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A. GLENN, G. M., RAO, M., RICHARDS, R. L., MATYAS, G. R., and ALVING, C. R. Immunol. Lett., 1995, 47 (1, 2), 73–78.
  • Antiphospholipid antibody binding to bilayer-coated glass microspheres. °BRINGER, A. R., ROTE, N. S., and WALTER, A. y. Immunol. Methods, 1995, 185 (1), 81–93.
  • Interaction of liposomes with cells in vitro. LEE, K. D., and PAPAHADJOPOULOS, D. NATO ASI Ser, Ser H, Trafficking of Intracellular Membranes, 1995, 91, 265–285.
  • Liposome capillary electrophoresis for analysis of interactions between lipid bilayers and solutes. ZHANG, Y., ZHANG, R., HJERTEN, S., and LUNDAHL, P. Electrophoresis, 1995, 16 (8), 1519–1523.
  • Porphyrins as fluorescent probes for monitoring phase transitions of lipid domains in biological membranes. Factors influencing the microenvironment of haemato-porphyrin and protoporphyrin in liposomes. RICCHELLI, F., and GOBBO, S. .7. Photochem. Photobiol., B, 1995, 29 (1), 65–70.
  • A liposome based immunosensor. KAMEI, H. Zairyo Kagaku, 1994, 31(6), 291–295.
  • Mechanism of liposome destabilization by polycationic amino acids. EPAND, R. NI., and LIM, W. Biosci. Rep., 1995, 15 (3), 151–160.
  • Entropic contribution to the stability of multilamellar liposomes. POPESCU, D. Rom. y. Biophys., 1993, 3(2), 113–121.
  • Specific binding of avidin to biotin containing lipid lamella surfaces studied with monolayers and liposomes. Liu, Z., QiN, H., XIAO, C., WEN, C., WANG, S., and Sol, S. Eur. Biophys. y., 1995, 24 (1), 31–38.
  • Chelators of iron ions: desferoxamine and EDTA inhibit hypochlorite-induced peroxidation of phosphatidylcholine liposomes by scavenging of HOCL/OC1-. PANASENKO, 0. NI., ARNHOLD, J., ARNOLD, K., SERGIENKO, V. I., and VLADIMIROV, Y. A. Biol. Membr., 1995, 12 (3), 294–302.
  • Mechanisms of liposome formation. LASIC, D. D. y. Liposome Res., 1995, 5(3), 431-441. Introducing a new element-fluorine-into the liposomal membrane. Riess, J. G. y. Liposome Res., 1995, 5 (3), 413–430.
  • Liposomes recognized as osmometers. DE GIER, J. y. Liposome Res., 1995, 5 (3), 365–369.
  • Botulinum toxin type A inhibits Ca2+-dependent transport of acetylcholine in reconstituted giant liposomes made from presynaptic membranes from cholinergic nerve terminals. LOPEZ, A. E., CANAVES, J., ARRIBAS, NI., CASANOVA, A., MARSAL, J., GONZALEZ, R. J. NI., and SOLSONA, C. Neurosci. Lett., 1995, 196 (1, 2), 37–40.
  • The binding of glutamate to glutamate receptors reconstituted in liposomes of different phospholipid composition. ZHARIKOV, S. I., SUKHANOV, S. V., and BARSUKOV, L. I. Biol. Membr., 1995, 12 (3), 303–309.
  • Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation in vivo. SUZUKI, H., NODA, Y., PAUL, S., GAO, X. P., and RUBINSTEIN, I. Life Sc., 1995, 57 (13), 1451–1457.
  • Liposome-mediated in vivo gene transfer into different tissues of the gastrointestinal tract. SCHMID, CHMID. NI., WEIDENBACH, H., DRAENERT, G. F., LERCH,M., LIPTAY, S., SCHORR, J., BECKH,K. H., and ADLER, G. Z. Gastroenterol., 1994, 32(12), 665–670.
  • Effects of alpha-trinositol administered extra- and intracellularly (using liposomes) on rat aorta rings. BRAILOIU, E., BALTATU, O., COSTULEANU, M., SLATINEANU, S., FILIPEANU, C., and BRANISTF.ANU, D. Fur. J. Pharmacol., 1995, 281 (2), 209–212.
  • Cooperative inhibitory effect of N, N, N-trimethylsphingosine and sphingosine-l-phosphate, co-incorporated in liposomes, on B16 melanoma cell metastasis: cell membrane signaling as a target in cancer therapy. IV. PARK, Y. S., RUAN, F., HAKONIORI, S. I., and IGARASHI, Y. Int. y. Oncol., 1995, 7 (3), 487–494.
  • Liposomal MTP-PE: a promising new biologic response modifier. GANO, J. B., and KLEINERNIAN, E. S. Oncol. Nurs. Forum, 1995, 22 (5), 809–816.
  • Histochemocal and electron microscopic charaterization of hepatic macrophage subfrac-tions isolated from normal and liposomal muramyl dipeptide treated rats. HOEDEMAKERS, R. M., ATNIOSOERODJO, B. J. E., MORSELT, H. W., DAENIES, T., SCHERPHOF, G. L., and HARDONK, M. J. Liver, 1995, 15 (3), 113–120.
  • Structural modulation of lipid peroxidation by the proteins within membranes: model protein studies with liposomes. RIEDL, A., ANDERTON, M., SHANISI, Z., GOLDFARB, P., and WISEMAN, A. Biochem. Soc. Trans., 1995, 23 (2), 251S.
  • Methods for assessing splenic macrophage depletion by liposome encapsulated clodronate. CANIILLERI, ANIILLERI. P., WILLIAMS, A. S., Amos, N., DOUGLAS, J. A. G., LOVE, W. G., and WILLIAMS, B. D. Intiamm. Res., 1995, 44(4), 152–157.
  • Immobilized-liposome chromatographic analysis of drug partitioning into lipid bilayers. BEloi, F., YANG, Q., and LUNDAHL, P. y. Chromatogr. A., 1995, 704 (2), 315–321.
  • Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and micro-spheres. HAUSBERGER, A. G., and DELucA, P. P. J. Pharm. Biomed. Anal., 1995, 13 (6), 747–760.
  • Delivery of protein into cells using polycationic liposomes. SELLS, M. A., Li, J., and CHERNOFF, J. Biotechniques, 1995, 19 (1), 72–78.
  • A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. MEN, Y., THOMASIN, C., MERKLE, H. P., GANDER, B., and CORRADIN, G. Vaccine, 1995, 13 (7), 683–689.
  • Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae. JoNEs, D. H., MCBRIDE, B. W., JEFFERY, H., O'HAGAN, D. T., ROBINSON, A., and FARRAR, G. H. Vaccine, 1995, 13 (7), 675–681.
  • Potentiality of gelatin microsphere as immunological adjuvant. NAKAOKA, R., TABATA, Y., and IKADA, Y. Vaccine, 1995, 13(7), 653–661.
  • Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes. Zuou, F., KRAEHENBUHL, J. P., and NEUTRA, M. R. Vaccine, 1995, 13 (7), 637–644.
  • Biodegradable microspheres. XVIII: The adjuvant effect of polyacryl starch microparticles with conjugated human serum albumin. DEGLING, I., and STJARNKVIST, P. Vaccine, 1995, 13 (7), 629–636.
  • Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigen. DE HAAN, A., RENEGAR, K. B., SMALL, P. A. JR., and WILSCHUT, J. Vaccine, 1995, 13 (7), 613–616.
  • Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA. HEEREMANS, J. L., PREVOST, R., BEKKERS, M. E., Los, P., EmEis, J. J., KLUFT, C., and CROMNIELIN, D. J. Thromb. Haemost., 1995, 73 (3), 488–494.
  • Accelerated degradation test of lyophilized recombinant tissue factor-liposome preparations. VAN DEN BESSELAAR, A. M., SCHAEFER VAN MANSFELD, H., MEEUWISSE BRAUN, J., and STREBUS, A. Thromb. Haemost., 1995, 73 (3), 392–397.
  • Effect of liposomal and free bisphosphonates on the IL-1 beta, and TNF alpha secretion from RAW 264 cells in vitro. PENNANEN, N., LAPINJOKI, S., URTTI, A., and MONKKONEN, J. Pharm. Res., 1995, 12 (6), 916–922.
  • The fibroblast-populated collagen microsphere assay of cell traction force. Part 2: Measure-ment of the cell traction parameter. BARACAS, V. H., MOON, A. G., and TRANQUILLO, R. T. y. Biomech. Eng., 1995, 117 (2), 161–170.
  • Long circulating liposomes. ()Ku, N., and NANIBA, Y Crit. Rev. Ther. Drug Carrier Syst., 1994, 11 (4), 231–270.
  • Lipid microspheres for drug delivery from the pharmaceutical viewpoint. YAMAGUCHI, T., and MIZUSHINIA, Y Crit. Rev. Ther. Drug Carrier Syst., 1994, 11 (4), 215–229.
  • Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma-a multicenter randomized double-blind study. Fox, L. E., MAcEwEN, E. G., KURZNIAN, I. D., DUBIELZIG, R. R., HELFAND, S. C., VAIL, D. M., KISSEBERTH, W., LONDON, C., IVIADEWELL, B. R., RODRIGUEZ, C. 0. JR., et al. Cancer Biother., 1995, 10 (2), 125–130.
  • An intramolecular disulfide bond is essential for annexin I-mediated liposome aggregation. Liu, L., and ZIMMERMAN, U. J. Biochem. Mol. Biol. Int., 1995, 35 (2), 345–350.
  • Interactions between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies. HOFLAND, H. E., BOUWSTRA, J. A., BODDE, H. E., SPIES, F., and JUNGINGER, H. E. Br. J. Dermatol., 1995, 132 (6), 853–866.
  • Error analysis of table look-up method for cerebral blood flow measurement by 123I-IMP brain SPECT: comparison with conventional microsphere model method. ITo, H., ISHII, K., ATSUMI, H., KINOSHITA, T., KAWASHINIA, R., ONO, S., YOSHIOKA, S., IIDA, H., UEMURA, K., and FUKUDA, H. Ann. Nucl. Med., 1995, 9 (2), 75–80.
  • Studies on gelatin microspheres-in-oil emulsion of pingyangmycin. Li, H. S., WEI, S. L., and Lu, W. Yao Hsueh Hsueh Pao, 1995, 30 (5), 390–394.
  • Inhibitory effect of simultaneous intraportal administration of 5-fluorouracil, uracil and degradable starch microspheres on experimental hepatic micrometastasis of colon cancer. NAKASAKI, H., HANAUE, H., YASUDA, S., FUJII, K., TAJIMA, T., MiTomi, T., and KUROSAWA, T. Tokai y. Exp. Clin. Med., 1994, 19 (1-2), 83–91.
  • Analysis of interactions between the corneal epithelium and liposomes: qualitative and quantitative fluorescence studies of a corneal epithelial cell line. PLEYER, U., GRANINIER, J., KOSMIDIS, P., and RUCKERT, D. G. Surv. Ophthalmol., 1995, 39 (Suppl 1), S3–16.
  • Biodegradable polymer microspheres for targeted drug delivery to the retinal pigment epithelium. OGURA, Y., and KINIURA, H. Surv. Ophthalmol., 1995, 39 (Suppl 1), S17–S24.
  • Functional reconstitution of ion channels from Paramecium cortex into artificial liposomes. ZHOU, X. L., CHAN, C. W., SAIMI, Y., and KUNG, C. y. Membr. Biol., 1995, 144 (3), 199–208.
  • Sterically stabilized liposomes labeled with indium-111 to image local infection. BOERNIAN, 0. C., STORM, G., OYEN, W. J., VAN BLOOIS, L., VAN DER MEER, J. W., CLAESSENS, R. A., CROMMELIN, D. J., and CORSTENS, F. H. y. Nucl. Med., 1995, 36 (9), 1639–1644.
  • Oral inoculation of mice with low doses of microencapsulated, non-infectious rotavirus induces virus-specific antibodies in gut-associated lymphoid tissue. KHOURY, C. A., IVIosea, C. A., SPEAKER, T. J., and OFFIT, P. A. J. Infect. Dis., 1995, 172 (3), 870–874.
  • Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intra-macrophage Mycobacterium avium-Mycobacterium intracellulare. ONYEJI, C. 0., NIGHTINGALE, C. H., TESSIER, P. R., NICOLAU, D. P., and Bow, L. My. Infect. Dis., 1995, 172 (3), 810–816.
  • Surface modification of albumin microspheres. SHAFI, Z. B., MARTIN, G. P., OLLIFF, C. J., and JAMES, S. L., J. Drug Target, 1995, 3 (1), 53–56.
  • The in vitro characterisation and biodistribution of some non-ionic surfactant coated liposomes in the rabbit. KHATTAB, M. A., FARR, S. J., TAYLOR, G., and KELLAWAY, I. W. J. Drug Target, 1995, 3 (1), 39–49.
  • The effect of dose on the distribution of adriamycin encapsulated in polyethyleneglycol-coated liposomes. SADZUKA, Y., NAKAI, S., MIYAGISHINIA, A., NOZAWA, Y., and HIROTA, S. J. Drug Target, 1995, 3 (1), 31–37.
  • Effects of bacteriohopane-32-ol on the stability of various kinds of liposomal membranes. CFIEN, Z., TANNO, N., TAKENAKA, S., and Suzuxi, Y. Biol. Pharm. Bull., 1995, 18 (4), 600–640.
  • Effect of cetylmannoside modification on the alternative complement pathway activation by liposomes in rat serum. MATsuo, H., YAMASHITA, C., AKIYAMA, K., and KIWADA, H. Biol. Pharm. Bull., 1995, 18 (4), 581–585.
  • Influence of surface coverage with poly(ethylene oxide) on attachment of sterically stabilized microspheres to rat Kupffer cells in vitro. HARPER, G. R., DAVIS, S. S., DAVIES, M. C., NORMAN, M. E., TADROS, T. F., TAYLOR, D. C., IRVING, M. P., WATERS, J. A., and WATTS, J. F. Biomaterials, 1995, 16 (6), 427–439.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.